Regulatory22 Apr 2026, 01:29 pm
CTLLAB Exempt from RPT Disclosure for FY26
AI Summary
Clinitech Laboratory Ltd (CTLLAB) has filed an undertaking confirming the non-applicability of disclosure requirements under Regulation 23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, concerning Related Party Transactions (RPT). This exemption is valid for the half-year and financial year ending March 31, 2026. The company qualifies for this exemption under Regulation 15 of SEBI (LODR) Regulations, 2015, as it is listed on the SME portal of BSE Limited and does not exceed the specified threshold limits for RPT disclosures.
Key Highlights
- CTLLAB is exempt from SEBI Reg 23 RPT disclosure requirements.
- Exemption applies for the half-year and full financial year ending March 31, 2026.
- The company is listed on the BSE SME portal.
- Exemption is due to not exceeding specified threshold limits.
- This reduces compliance burden for the company.
Price Impact
More from CTLLAB